Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg Dexamethasone

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Diabetic Macular Edema
Interventions
DEVICE

Ozurdex

Dexamethasone implant (Ozurdex)

Trial Locations (1)

EC1V 2PD

Moorfields Eye Hospital NHS Foundation trust, London

All Listed Sponsors
collaborator

The Royal Wolverhampton Hospitals NHS Trust

OTHER_GOV

collaborator

Frimley Park Hospital NHS Trust

OTHER

collaborator

Brighton and Sussex University Hospitals NHS Trust

OTHER

collaborator

University Hospitals Bristol and Weston NHS Foundation Trust

OTHER

lead

Moorfields Eye Hospital NHS Foundation Trust

OTHER

NCT01892163 - Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg Dexamethasone | Biotech Hunter | Biotech Hunter